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Abstract: In adults, fermentation of high amylose maize starch (HAMS), a resistant starch (RS), has
a prebiotic effect. Were such a capacity to exist in infants, intake of RS might programme the gut
microbiota during a critical developmental period. This study aimed to determine if infant faecal
inocula possess the capacity to ferment HAMS or acetylated-HAMS (HAMSA) and characterise
associated changes to microbial composition. Faecal samples were collected from 17 healthy infants
at two timepoints: Preweaning and within 10 weeks of first solids. Fermentation was assessed using
in vitro batch fermentation. Following 24 h incubation, pH, short-chain fatty acid (SCFA) production
and microbial composition were compared to parallel control incubations. In preweaning infants,
there was a significant decrease at 24 h in pH between control and HAMS incubations and a significant
increase in the production of total SCFAs, indicating fermentation. Fermentation of HAMS increased
further following commencement of solids. Fermentation of RS with weaning faecal inocula increased
Shannon’s diversity index (H) and was associated with increased abundance of Bifidobacterium and
Bacteroides. In conclusion, the faecal inocula from infants is capable of RS fermentation, independent
of stage of weaning, but introduction of solids increases this fermentation capacity. RS may thus
function as a novel infant prebiotic.
Keywords: short-chain fatty acid (SCFA); pH; dietary fibre; gut health; prebiotic
1. Introduction
The initiation of solid foods in early infant feeding represents a dynamic period of change in the
composition of the gut microbiota [1]. This period is also critical to child development with implications
for general nutrition and immune development, amongst other benefits [1]. The administration of
prebiotics during this period could have profound health consequences [2] as they are non-digestible,
generally safe and inexpensive food ingredients that selectively stimulate the growth and/or activity of
one or a limited number of bacterial species that already reside in the colon [3].
In adults, high amylose maize starch (HAMS), a cultivar obtained through selective breeding, may
function as a prebiotic [4]. It is a form of resistant starch (RS), which is defined as the sum of starch
and products of starch degradation which have not been absorbed in the small intestine of healthy
individuals and which become available for microbial fermentation in the colon [5]. RS is classified
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into five types and several of these starches have been shown to alter gut fermentation and change
gut microbial composition [5]. HAMS is an example of a type 2 RS. Starches may also be chemically
modified (type 4 RS) to reduce their digestibility and obtain favourable physicochemical properties.
Acylated type 4 RSs may also increase the delivery of short-chain fatty acids (SCFAs) directly to the
colon. One example of this is acetylated-HAMS (HAMSA), which is esterified with acetyl groups.
Due to significant differences in the composition and function of infant and adult gut microbiota,
the potential of RS to function as a prebiotic in infants cannot be extrapolated from adult studies. It is
possible that the relatively immature gut microbial ecosystem of the infant may not have acquired the
necessary diversity of bacteria to ferment a complex carbohydrate such as RS [6,7].
Due to the relative inaccessibility of the proximal colon and portal vein, in vivo measurement
of substrate digestion and fermentation requires highly invasive procedures and feeding studies to
preweaning infants that are not practical. In vitro static batch fermentation is a rapid, inexpensive
method to initially assess substrate fermentation and has been widely used to evaluate the fermentation
capacity of both adult and infant faecal inocula [8,9]. Substrate fermentation during in vitro batch
fermentation studies is evidenced by substrate disappearance, increased production of SCFAs, a decrease
in pH, gas generation, or differences in microbial composition in those ferments containing the substrate
when compared to a control. The control incubation does not have an added substrate.
In the present study, we used an in vitro batch fermentation system that simulates human colonic
fermentation to determine: (1) The capacity of infant faecal inocula, pre-weaning and weaned, to
ferment pre-digested HAMS and HAMSA by monitoring changes in the activity (fermentation) and
community structure of the faecal microbiota of preweaning and early weaning infants; and (2) whether
the introduction of solids into the diet (weaning) influences these variables.
2. Materials and Methods
2.1. Study Design
We conducted an observational study in which faecal samples were collected from infants, prior
to and following weaning (commencement of first solid foods). The first faecal sample was collected
from 8 weeks of age until weaning, while the second sample was collected within 10 weeks of weaning
commencing. Collected samples were incubated in vitro with fermentable substrates to address the
aims. Each infant was expected to provide two samples, one for each time point. This study complied
with National Health and Medical Research Council (Australia) guidelines relating to ethical conduct in
human research and was reviewed and approved by the Southern Adelaide Clinical Human Research
Ethics Committee (September 2013, 339.13).
2.2. Participants and Intervention
Caregivers of preweaning infants were recruited either by direct approach following childbirth
and prior to hospital discharge or through advertisements in a local parenting magazine. Inclusion
criteria included that the infant was full term at birth with a gestational age of more than 38 weeks; at or
above the 10th percentile for weight at birth and with no known cardiac, respiratory or gastrointestinal
disease. Infants were excluded if they or their mothers received probiotic supplementation or antibiotics
post-delivery and prior to stool collection. The mode of infant feeding, breastfed or bottle-fed or mixed
(not exclusively breast fed), was recorded. There were 17 preweaning infants and 16 of these infants
went on to provide weaning samples.
2.3. Faecal Sample Collection and Processing
Within 15 min of an infant passing a motion, stool was collected from a disposable nappy using a
sterile container, placed into an airtight bag and put into a portable freezer set at −20 ◦C. Within two
hours, the sample was processed in the laboratory. Working within an anaerobic cabinet containing
5% H2, 5% CO2, and 90% N2, the faecal samples were homogenised in 50% glycerol (1:1 dilution)
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and stored at −80 ◦C until further analysis. The use of frozen samples compared to fresh samples in
fermentation experiments has been previously validated [10].
2.4. Carbohydrates and Chemicals
The two RSs, HAMS (Hylon VII) and modified HAMS (HAMSA-Crispfilm) were obtained from
Ingredion, USA. Hylon VII is composed of 70% amylose and 30% amylopectin. It is estimated that
Hylon VII contains 50 g of RS per 100 g [11]. Crispfilm (CF) has a Hylon VII backbone and has
undergone a further esterification process to form a starch acetate. The degree of acetylation of CF is less
than 2.5%, the limit imposed by U.S. Food and Drug Administration (FDA) food regulation and CF has
Generally Recognized as Safe (GRAS) status. Lactulose was obtained from Sigma-Aldrich, Australia.
2.5. In Vitro Fermentation
An in vitro pre-digestion step was performed to simulate the digestive action of the infant small
intestine prior to the fermentation experiments [12]. See Appendix A.1, for further detail of the
pre-digestion method. The in vitro fermentation method was based on the technique described by
Edwards et al. [13] and Goni et al. [14]. For each preweaning infant sample there were three groups of
incubations: HAMS, lactulose and the control. The control incubation had no additional substrate and
lactulose was added to confirm that viable bacteria were present in the faecal inocula of each subject.
For weaning infant samples there were four incubations, with HAMSA as the additional group, along
with HAMS, lactulose and the control. HAMSA was not tested in preweaning infants due to small
sample volumes. All fermentations were performed in triplicate for each donor/substrate at 0 and 24 h
time points. Briefly, 100 mg of pre-digested starch residue was weighed into triplicate 15 mL sterile
culture tubes together with 8–10 sterile 2.5 mm glass beads and 9 mL of autoclaved fermentation media.
Frozen homogenised faecal material from participants was thawed and a 10% w/v faecal slurry was
prepared by homogenisation and dilution in pre-reduced phosphate-buffered saline (PBS) (0.1 M, pH
7.2). Working within an anaerobic chamber, 1 mL of faecal slurry was added to each fermentation tube
(1% w/v). Controls were incubated in parallel with incubations containing HAMS, lactulose or HAMSA.
Tubes were incubated under anaerobic conditions with gentle agitation for 24 h. Fermentation was
terminated at 0 h (Blanks) and at 24 h samples by centrifugation at 13,000× g, 4 ◦C for 10 min and the
supernatant was stored at −80 ◦C for further measurements.
2.6. SCFA and pH
SCFA concentration was determined using capillary column gas chromatography according to
McOrist et al. [15]. A digital pH meter was used to measure pH. Fermentation of the substrate was
deemed to have occurred if there was a statistically significant decrease in pH and an increase in
production of SCFA at 24 h in ferments containing added RS when compared to the respective control.
2.7. Molecular and Sequence Analysis
2.7.1. DNA Extraction
DNA was extracted from ferments using bead beating followed by the MoBio PowerMag
Microbiome RNA/DNA isolation kit (Qiagen, Hilden, Germany) optimised for epMotion (Eppendorf,
Hamburg, Germany) platforms (see Appendix A.2). Due to the recognised variation in fermentation
between replicates during in vitro batch fermentation [16], DNA was extracted from a pooled sample
containing 1 mL from each ferment replicate.
2.7.2. Real-time Quantitative Polymerase Chain Reaction (qPCR)
Selected bacteria including bifidobacterium, lactobacillus and total bacteria, were quantified by
specific primers targeting the 16S rRNA gene using qPCR. See Appendix A, Table A1, for primer
sequences and the optimised qPCR conditions. The ability of a substrate to selectively stimulate
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the growth of a given bacterial taxon was determined by comparing incubations with either HAMS
or HAMSA to the 24 h control. All qPCR analysis was performed on the CFX 384TM real-time
PCR detection system (Bio-Rad, Hercules, CA, USA) (See Appendix A.3). Absolute abundance was
estimated according to Christophersen et al. [17].
2.7.3. Sequencing of 16S Ribosomal RNA Encoding Gene Amplicons
16S ribosomal DNA gene sequencing was performed on DNA extracted from each participant’s
24 h fermentation samples (preweaning control, preweaning HAMS, weaning HAMS, weaning
HAMSA, weaning control). The 24 h samples were chosen as the fermentation is not only affected
by the added substrate but also by the remaining substrates in the faecal slurry. We therefore believe
the true control for each subject and substrate is a control fermentation with no added substrate to
take into account the available substrate in the faecal slurry. The methods outlined in Illumina’s 16S
Metagenomic Sequencing Library Preparation protocol (Illumina, San Diego, CA, USA) were followed
with minor adjustments made to PCR thermal cycle conditions, as described in Appendix A.4.
2.7.4. Taxonomic Assignments to 16S Reads
An in-house (CSIRO) amplicon clustering and classification pipeline (GHAP) based on tools from
Usearch [18] and a Ribosomal Database Project (RDP) classifier [19] combined with locally written tools
for demultiplexing and generating Operational Taxonomic Unit (OTU) tables were used to process
the amplicon sequence data. Following the merging of paired reads, dereplication, clustering at 97%
and chimera checking were also performed using the pipeline. Classification of the reads was then
performed by using the RDP to assign taxonomy and by finding the closest match to the OTU from a
set of reference 16S sequences [19]. OTUs were defined at a 97% sequence similarity level and classified
to genus level. Sequences which were not classified using the pipeline were manually blasted against
the NCBI database.
2.8. Statistical Analysis
For SCFA and pH results, data normality was assessed using the Shapiro–Wilk test using SPSS
Version 22.0. A boxplot of the dataset was used to identify outliers within preweaning and weaning
groups, Univariate ANOVA with Bonferroni correction was used to analyse for differences in starting
pH and total SCFA of the different groups within the weaning and preweaning infants. Due to
differences in the number of formula and breastfed infants, a general linear mixed model was used to
determine if within the preweaning group, the method of feeding influenced the effect of incubation
with HAMS on both change in pH and total SCFA production. A repeated measures two-factor
ANOVA was used to determine if there was an effect of weaning on parameters of HAMS fermentation
(pH and total SCFA) when compared to controls. Values are presented as means ± their standard
errors. Statistical significance was accepted as p < 0.05.
For analysis of the molecular results, the qPCR values were log10 transformed and the means
were compared using Student’s t-test. Microbial abundance at 24 h was compared with those at 0 h for
each substrate. Multivariate analysis of the sequencing data was performed using PRIMER 7 with
PERMANOVA (PRIMER-e, Auckland, New Zealand). Statistical analysis of Bray-Curtis dissimilarities
were calculated using relative abundance of bacterial genera at the family level following 24 h of
fermentation. Alpha diversity index was also calculated at the family level. Principal coordinate
analysis (PCOA) was used to visualise the dissimilarity data.
3. Results
The seventeen participants provided a preweaning sample, with all but one of these infants also
providing a second (weaning) sample (see Table 1).
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Table 1. Description of infants used as faecal donors for in vitro fermentation experiments.
Participants Preweaning(n)
Weaning
(n)
Age Preweaning
Sample (Months)
Mean ± SE
Age Weaning
Sample (Months)
Mean ± SE
Exclusively Breast-Fed 10 10 3.32 ± 0.37 a 7.03 ± 0.27 b
Mixed 7 6 3.29 ± 0.22 a 7.39 ± 0.21 b
Total 17 16 3.31 ± 0.23 7.16 ± 0.18
SE: Standard error. Means in a row without a common superscript letter differ significantly (p < 0.05).
3.1. SCFA and pH Levels
The Shapiro–Wilk test confirmed a normal distribution of faecal pH and SCFA data in both
preweaning and weaning incubation samples. One participant, in the preweaning exclusively
breast-fed group, was noted to have an outlier for total SCFA for each substrate. Parallel series of
calculations performed with and without the inclusion of this participant’s data did not alter the final
statistical conclusions. Within the preweaning group, linear mixed model analysis revealed no effect of
mode of feeding (exclusively breast fed or mixed) on SCFA (p = 0.754) or pH (p = 0.809), following
incubation with either substrate (HAMS or lactulose).
Results for initial, final and change in pH at 24 h following incubation are presented in Table 2.
All incubations, including the lactulose, resulted in a significant decrease in pH at 24 h. In both
weaning and preweaning groups the decrease in pH was significantly greater following incubation
with HAMS than in the controls, consistent with active fermentation of HAMS. It was expected to
observe a decrease in pH for control samples due to residual substrate in the faecal inoculate. In the
weaning group, incubation with HAMSA also led to a decrease in pH when compared to the control.
Table 2. Initial and final change in pH following incubation of infant faecal microbiota with high
amylose maize starch (HAMS) and other substrates. Mean ± SE.
Preweaning Weaning
Control HAMS Lactulose Control HAMS HAMSA Lactulose
Initial pH
(0 h) 7.64 ± 0.03
a 7.63 ± 0.03 a 7.69 ± 0.03 a 7.66 ± 0.03 a 7.65 ± 0.02 a 7.65 ± 0.03 a 7.72 ± 0.04 a
Final pH
(24 h) 6.72 ± 0.08
a 6.40 ± 0.09 b,* 4.73 ± 0.12 c,* 6.77 ± 0.05 a 6.43 ± 0.05 b,* 6.37 ± 0.04 b,* 4.65 ± 0.08 c,*
∆ pH −0.93 ± 0.07 a −1.21 ± 0.06 b,* −3.03 ± 0.06 c,* −0.82 ± 0.07 a −1.14 ± 0.08 b,* −1.09 ± 0.10 b,* −2.89 ± 0.20 c,*
Within the preweaning and weaning groups a one-way ANOVA was used. Unlike superscript letters within each
row are significantly different (Bonferroni adjusted p < 0.05). * defined as different from control (p < 0.05). HAMSA:
High Amylose Maize Starch Acetylated.
Analysis of variance showed no effect of the substrates on initial pH, p = 0.36. A repeated measures
two-factor ANOVA revealed an effect of HAMS p < 0.001, but not stage of weaning on change in pH,
p = 0.34. There was no interaction between the substrate and stage of weaning p = 0.54, indicating
that the introduction of solids did not influence the effect of incubation with HAMS on change in pH
when compared to controls. The means and standard error thereof for total and major individual
production of SCFAs at 24 h are shown in Table 3. In the faecal inocula of the preweaning group there
was a significant increase in the concentration of SCFAs, acetate and butyrate when HAMS was added
compared to the controls, indicating that the preweaning faecal inocula had some capacity to utilise
HAMS as a substrate.
In the faecal inocula from weaned infants, there was a significant increase in the production of
total SCFAs, acetate and propionate for both HAMSA and HAMS. A significant increase in butyrate
was seen only with HAMS and not HAMSA. These changes confirmed fermentation of the RSs by the
infant faecal inocula. The molar ratios for all the substrates confirmed previous findings that, in young
infants, acetate is by far the dominant SCFA during fermentation.
In relation to total SCFA concentration, a two-way repeated measures ANOVA demonstrated a
significant interaction between incubation with HAMS and stage of weaning, p = 0.015, suggesting that
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the fermentation of HAMS is enhanced post the introduction of solids. A pair-wise comparison with
Bonferroni correction revealed no statistically significant effect of weaning on total SCFA concentration,
p = 0.06. However, there was a statistically significant effect for HAMS p < 0.001.
Table 3. Short-chain fatty acid (SCFA) concentrations (mmol/L) following incubation with test substrates
using pre- and weaning infant faecal inoculum. Mean ± SE.
Preweaning Weaning
Control HAMS Lactulose Control HAMS HAMSA Lactulose
Total SCFA # 16.68 ± 1.7 a 23.70 ± 1.7 b,* 61.84 ± 5.4 c,* 20.11 ± 2.3 a 34.85 ± 4.0 b,* 37.81 ± 4.2 b,* 78.27 ± 4.5 c,*
Acetate 14.70 ± 1.5 a 20.93 ± 1.5 b,* 56.11 ± 6.5 c,* 16.98 ± 2.1 a 27.73 ± 3.3 b,* 30.27 ± 3.1 b,* 73.42 ± 5.0 c,*
Propionate 0.83 ± 0.17 a 1.33 ± 0.33 a 1.13 ± 0.80 a 1.60 ± 0.32 a 4.14 ± 0.91 b* 5.56 ± 1.2 c* 2.89 ± 0.74 a,b,c,*
Butyrate 0.36 ± 0.13 a 0.74 ± 0.26 b 0.27 ± 0.12 a 1.09 ± 0.26 a 2.20 ± 0.59 b* 1.23 ± 0.33 a 1.81 ± 1.1 a
# Total SCFA (mmol/L) = sum of acetate, propionate, butyrate and minor SCFAs (valeric, caproic, isobutyric,
isovaleric). Within the preweaning and weaning groups a one-way ANOVA was used. Unlike superscript letters
within each row are significantly different (Bonferroni adjusted p < 0.05). * defined as different from control (p < 0.05).
3.2. Microbial Community Analysis
Across all samples collected at 24 h there were 321 operational taxonomic units identified, with
an average of 94 OTUs per sample (59–213). For preweaning faecal fermentation samples, a total of
632,032 usable reads were obtained and for weaning, 873,706 reads were obtained for downstream
analysis. DNA from two samples from the preweaning group failed to amplify during library
preparation for unknown reasons and therefore these participants were omitted from sequence analysis.
Sequences were classified at each phylogenetic level from phylum to genus.
3.2.1. Alpha Diversity
Alpha diversity was calculated in this study, although the study uses an in vitro model (closed
system), because changes in diversity can still be observed as the Shannon index combines species
richness and their relative abundances. In the preweaning group at 24 h of incubation, there was
no significant difference in the Shannon Index between bacterial communities following incubation
with HAMS or the controls. For example, at the family level, a one-way ANOVA determined that, in
the preweaning group, the overall mean of the log(e) of the Shannon Index did not differ between
the control and the HAMS incubations (p = 0.10). The Shannon Diversity Index boxplot based on
OTU abundance at the family level is presented in Figure 1A. In the weaning group, at the family
level, there was a significant increase in the Shannon index in the RS groups compared to the controls
(p = 0.05). However, the type of RS (HAMSA or HAMS) did not have an effect on this measure of
diversity. The Shannon Diversity Index boxplot based on OTU abundance at the family level for the
weaning infants is presented in Figure 1B.
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Figure 1. Boxplot of diversity at family level in (A) preweaning and (B) weaning infant faecal inocula
following 24 h in vitro fermentation. Boxes indicate 25th to 75th percentiles, with mean values marked
as a line and whiskers indicating minimum and maximum values. Different letters mean significantly
different from each other (p < 0.05).
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3.2.2. Beta Diversity
Among the preweaning samples, multivariate analysis did not reveal an effect of HAMS on
microbial community structure (p > 0.05). However, in the weaning samples, the effect of both HAMS
and HAMSA were significant (p < 0.05), compared to the controls. Pairwise comparison was performed
to investigate the differences between the two test groups. This demonstrated that both RSs had a
similar effect on community structure (p = 0.97) (see Figure 2). It is apparent that samples from the
same individual clustered closely.
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3.2.3. Relative Abundance
In order to identify th changes in the comp sitio of bacterial communities that might utilise the
RSs, the relative abundance of bacterial groups in fermentation fluid at 24 h of incubation was assessed.
The relative abundance was calculated and is presented in Appendix A, Table A2. Across all levels
of classification, there were a number of statistically significant differences in the relative abundance
of bacteria between HAMS nd controls in th weaning group when compared to the preweaning
group. At the phyla level in weaning infants, there was a significant increase in the proportion of
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Actinobacteria and Bacteroidetes at 24 h of fermentation for both RSs in comparison to the controls
(p < 0.05). There was also a significant reduction in Proteobacteria following incubation with both
HAMS and HAMSA (p < 0.05). At a genus level in weaning infants, the abundances of Bacteroides
and Bifidobacterium were significantly increased following incubation with the RSs when compared to
controls (p < 0.05).
Incubation with both HAMS and HAMSA led to a concomitant reduction in the relative abundance
of Enterobacter. Compared to the control, the relative abundance of Ruminococcus was significantly
increased following incubation with HAMSA (p = 0.01), but not HAMS (p = 0.58). Figure 3 illustrates
microbial composition after 24 h of fermentation at a genus level for each substrate, with a relative
abundance threshold of 0.1%.
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Figure 3. Genus-level composition of the microbial community after sequencing. DNA from 24 h
in vitro fermentations of infant faecal inocula. Bacterial genus with a relative abundance of less than
1% are grouped as “other”.
3.2.4. Quantitative PCR
All qPCR assays had previously been verified using single cell colony sequencing and they
were found to be 100% specific to the bacterial group assigned. In preweaning infants, the absolute
abundance for total bacteria increased after 24 h of fermentation in HAMS and controls (see Table 4)
compare to time 0 h in the controls (representative of the baselin ). However, at 24 h the absolute
abundance of total bacteria, bifidobacteria and Lactobacillus did not differ between the c ntrol and
the HAMS incubations. In the weaning infants, foll wing 24 h of in vitro fermentation, the absolute
abundance of total bacteria, bifidobacteria and Lactobacillus increased in all three groups (control,
HAMS and HAMSA) compared to time 0 h controls. While there was no difference in the absolute
abundance of total bacteria or Lactobacillus at 24 h compared to the control, the absolute abundance of
Bifidobacterium was significantly greater in HAMS and HAMSA compared to controls. This indicates
that both RS’s can stimulate the growth of Bifidobacterium in the faecal microbiota of weaning infants.
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Table 4. 16S rDNA copy numbers (log 10 copy numbers mL−1 fermentation effluent) of specific bacterial
groups before (0 h) and after 24 h of in vitro fermentation with infant faecal inocula and test substrates,
as determined by qPCR. Mean ± SE.
Total Bacteria Lactobacillus Bifidobacterium
Substrate 0 h 24 h 0 h 24 h 0 h 24 h
Preweaning control (n = 17) 6.6 ± 0.15 7.18 ± 0.24 a,* 4.26 ± 0.4 4.19 ± 0.23 a 6.06 ± 0.09 6.08 ± 0.32 a
HAMS (n = 17) 7.21 ± 0.1 a,* 4.02 ± 0.28 a 6.39 ± 0.25 a
Weaning
Control
(n = 16) 6.65 ± 0.07 7.32 ± 0.06
a,* 2.9 ± 0.27 3.34 ± 0.86 a 5.09 ± 0.31 5.56 ± 0.21 a
HAMSA
(n = 16) 7.42 ± 0.06
a,* 3.52 ± 0.91 a 6.21 ± 0.10 b,*
HAMS
(n = 15) 7.47 ± 0.05
a,* 3.49 ± 0.89 a 6.04 ± 0.19 b,*
In the preweaning and weaning groups, within column values which do not share a superscript letter are significantly
different (p < 0.05). * Significant difference between 0 and 24 h values for each substrate, p < 0.05.
4. Discussion
A divergence in the intake of fibre between those living in Western countries and those consuming
a predominantly agrarian diet, as occurs in many rural parts of the world, emerges as soon as solids are
introduced into the infant diet [1]. Thus, targeted manipulation of fibre content in the early diet may
affect the emerging gut microbiota during a critical period and lead to functional and compositional
changes which could benefit the host’s developing immune system [20,21]. It is within such a context
that we were interested in whether forms of RS, which function as a prebiotic in adults, could have a
role in infancy.
In both the weaning and preweaning groups, the production of SCFAs by the faecal inocula
from these infants was significantly greater in the presence of HAMS when compared to controls.
While fermentation might be expected in faeces from the weaning cohort, it is surprising that the
microbiota of preweaning infants already possess capacity to ferment starch. However, this capacity
did increase significantly post commencement of complementary feeds.
Previous results regarding the potential of young infant faecal bacteria to ferment complex
carbohydrates, are conflicting. An early study by Parrett et al. suggested that the capacity of human
faecal microbiota to ferment complex carbohydrates does not emerge for several months after solids are
commenced [6]. In contrast, Christian et al. found that the faecal microbiota of early weaning infants is
highly efficient at fermenting the digestible waxy maize starch [8]. Heterogeneity in methodologies
across in vitro fermentation studies, including the inclusion or exclusion of substrate pre-digestion, the
age of study participants and the preparation of faecal inocula, limits comparison of results across
studies. In this study, we used a substrate pre-digestion which reflects the low level of alpha-amylase
in the infant gut.
There was no significant difference in the production of total SCFAs, especially acetate, between
HAMS and HAMSA (which is acetylated HAMS). It might be that the degree of substitution was
insufficient for cleavage of the esterified acetate to achieve a statistically significant increase in the
overall pool of acetate. It could also be that infant microbiota might not have yet acquired the esterase
capacity needed to cleave the additional acetate.
Surprisingly, and despite the fermentation findings, our molecular findings showed little difference
in bacterial composition following incubation of HAMS with the preweaning infant inocula in
comparison to the controls. There were no selective differences in the abundance of groups of bacteria
following incubation of HAMS with the preweaning infant inocula, in comparison to the controls.
However, within ten weeks of commencing solids, the molecular changes within the weaning infant
faecal incubations suggest emergence of such a capacity. If selective stimulation of Bifidobacterium and
an increase in the production of SCFAs are components of the prebiotic definition [2] then, based on
these findings, HAMS and HAMSA may well function as a novel prebiotics during infancy.
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A significant number of Bifidobacterium spp. possess genes belonging to the GH13 family of glycosyl
hydrolases (GH) [22,23]. Enzymes belonging to this family are heavily involved in the degradation
of starch and starch related-substrates [24]. Despite the relatively high abundance of Bifidobacterium
in preweaning infant inocula, several possibilities exist for why there were no significant differences
in microbial profile between controls and substrate incubations. It could be that the significant
inter-individual variation in the gut microbial composition of preweaning infants might have masked
the capacity to establish substrate level differences in the microbial profile [25]. Another explanation
rests upon differences in metabolic function amongst various members of the Bifidobacterium genus.
Depending on the particular ecological niche, given the myriad of metabolic pathways available to
Bifidobacterium spp., selective pressure will support the growth of those Bifidobacterium spp. that are able
to utilise the substrates that are most available [22]. Metagenomic studies have demonstrated differences
in which bifidobacterial GH genes are transcribed between infants and adults [26]. For example,
in breast feeding infants, there is greater transcription of bifidobacterial GH genes that are involved
in the degradation of Human Milk Oligosaccharides (HMO) and mucin, compared to adults which
reveals a greater predominance of bifidobacterial GH encoding genes involved in the breakdown
of complex plant-derived carbohydrates [26]. Following the introduction of solids, when more
complex carbohydrates escape the digestive enzymes of the host and are encountered by the infant
gut microbiota, those microbial genes that are involved in the utilisation of these novel nutrients will
be switched on [27]. Given the immaturity of pancreatic function in the young infant, following the
initiation of solids, significant amounts of dietary starch will enter the infant’s colon. This will favour a
selective increase in the expression of genes associated with starch utilisation and may account for the
findings in the weaning faecal inocula.
Despite the recognised relevance of Bifidobacterium to starch utilisation, it had been suggested
that Ruminococcus bromii, a member of the Firmicutes, is a keystone species in the degradation of
HAMS [28]. Our results cannot confirm this assertion. While there was a selective increase in the
relative abundance of Ruminococcus spp. following incubation with HAMSA, there was no such
increase following incubation of HAMS with the weaning infant inocula. This was despite evidence
of starch utilization, as seen in the increase in the relative abundance of other groups of bacteria in
comparison to the controls. This suggests that many strains of bacteria are able to utilise HAMS, which
aligns with studies conducted in pigs [29,30]. Members of Bacteroidetes, a dominant bacterial phylum
in the mammalian gut, also encode numerous discrete polysaccharide utilisation loci (PULs) that may
facilitate starch utilisation. Incubation of weaning infant faecal inocula with both RSs led to an increase
in the relative abundance of Bacteroidetes and an increase in the ratio of Bacteroidetes:Firmicutes.
An increase in the ratio of Bacteroidetes:Firmicutes may be associated with several positive health
outcomes, including reduced risks of obesity and intestinal inflammation [31].
The concordance between HAMS and HAMSA in relation to the effects on microbial composition
and diversity observed in this study could be due to the minimal nature of the chemical modification.
The HAMSA starch used in this study is approved for consumption in infant foods. For starch acetate,
the FDA and the WHO have stipulated an acetyl group’s percentage below 2.5 g/100 g (corresponding
to a maximum Degree of Substitution (DS) of 0.1) for a food application. Although HAMS with higher
degrees of acetylation have been shown to facilitate increased delivery of SCFA into the human colon,
their comparable effects on the gut microbiota have not yet been examined [32].
In a study feeding modified and unmodified RS to adult participants, different effects on faecal
microbiota composition between the two starches were found [33]. The authors found the intake of
the modified, but not the unmodified starch, over a three-week period led to a significant increase in
the abundance of Actinobacteria and Bacteroides. Using our in vitro model, we demonstrated a similar
taxonomic effect following incubation of the weaning infant feces with the modified RS. However, in
contrast to Martinez et al. (2010) we found incubation of the unmodified RS led to similar taxonomic
changes at the phylum level. From a translational viewpoint, if HAMS is eventually used in infant nutrition,
the unmodified form may have greater appeal to caregivers due to its lack of chemical modification.
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Being an in vitro design, our study has inherent limitations. The high relative abundance of
Proteobacteria at 24 h of incubation, particularly in the controls, reflects a difference between in vitro
and in vivo conditions and suggests that in vitro conditions might have favoured the growth of
Proteobacteria. This also reflects that not all bacteria grow in vitro and faeces contain a large proportion
of dead bacteria which may not be representative of the living mucosal-adherent and/or luminal bacteria
in the gut. The limited availability of infant faecal inocula also precluded comparative evaluation of
the fermentation of the chosen RS to other substrates which may already be recognised as prebiotics in
infants, e.g., fructo-oligosaccharides (FOS). To circumvent this, it might have been possible to pool
the faecal samples from different donors. However, individual variation in the microbiota might be
greater than the effects of treatment.
A further limitation was that the actual degradation of the substrate in each ferment was not
measured. It is not uncommon for in vitro fermentation studies to omit this measurement, instead
relying, as we have done, on the products of fermentation and changes in microbial composition to
provide an estimate of fermentation. It should also be noted that, irrespective of the benefits to gut
health, RS may impact the nutritional status of the infant diet. Therefore, further studies are required
to determine a safe dose of RS for highly vulnerable populations, such as growing babies and children.
Ultimately, any claim to prebiotic status for HAMS during the infant period must be supported
by well-designed human studies. Inulin, fructo-oligosaccharides and galacto-oligosaccharides, the
subjects of several randomised controlled trials, are generally held to be the main substrates to have
prebiotic potential during infancy. However, these agents are costly to produce and, particularly in
the case of FOS and galacto-oligosaccharides (GOS) due to their small size, confer a luminal osmotic
effect and are rapidly fermented. These features carry the risk of precipitating undesirable clinical
effects, such as diarrhoea and abdominal discomfort. HAMS has several advantages. It can be readily
cultivated, is slowly fermented and does not produce an osmotic effect in the large intestine. It can also
be readily incorporated into foods without altering the processing or organoleptic properties [34].
5. Conclusions
This study confirms that faecal inocula, whether preweaning or at weaning infants has the
capacity to utilise HAMS and HAMSA as a potential substrate. Incubation with both starches
selectively stimulated Bifidobacterium copy numbers and increased the Bacteroidetes:Firmicutes ratio,
outcomes that, if replicated in direct feeding studies, may be associated with beneficial health outcomes.
These findings justify further in vivo infant studies to examine the short- and long-term effects of
different doses of HAMS during weaning on the composition and function of the emerging gut
microbiota and clinical outcomes.
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Appendix A
Appendix A.1. Pre-Digestion Method
5 g of test starch was accurately weighted into tubes (8) and incubated with 25 mL of pepsin
(1 g/mL, made up in 0.02 mol HCl/L, pH 2, for 30 min at 37 ◦C. The next phase of digestion was replicated
by neutralisation with sodium hydroxide (0.02 M) and incubation with 25 mL of amyloglucosidase
(200 U/mL) and alpha-amylase (1.5 U/mL) solution for 5 h in a shaking water bath at 37 ◦C. Following
the incubation, contents were pooled and transferred into a beaker containing 80% ethanol and left
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overnight. The supernatant was then removed and the residue was washed with 80% ethanol. This was
then centrifuged (2000× g for 10 min), followed by the removal of the supernatant. Washing with
alcohol, centrifuging and removal of the supernatant was repeated four times. Following air-drying
in the fume hood for another 24 h, the residue was collected for use in the small-scale batch in vitro
fermentation method. Only one batch of pre-digestion was performed for each substrate and this
provided sufficient amounts for all the required incubations.
Appendix A.2. DNA Extraction Method
DNA was extracted using the PowerMag Microbiome DNA Isolation kit (Qiagen, Hilden,
Germany) from a pooled sample containing 1 mL from each ferment replicate. No DNA was extracted
from ferments incubated with lactulose as human faecal microbiota of all age groups are recognised to
readily ferment lactulose. The purpose of incubation with the lactulose was only to confirm the viability
of the faecal microbiota from the particular participant. A sample of 1 mL from each of triplicate
ferments was transferred into three separate 2 mL Eppendorf tubes and centrifuged at 13,000× g at
4 ◦C for 5 min using a bench centrifuge (Eppendorf, Hamburg, Germany). Each resulting cell pellet
was retained and the supernatant discarded. Heated PowerMag Microbiome lysis solution (650 µL)
was added to the first of the three tubes (each containing the cell pellet) and mixed thoroughly. All the
solution was then transferred into the second tube, mixed, and the contents transferred into the third
tube, which was also subjected to vigorous mixing. Sterile 0.4 g PowerMag glass beads were added to
the final tube and the sample was homogenised for 3 min at maximum speed on a Mini-Beadbeater
(BioSpec Products, Bartlesville, OK, USA). The tube was then centrifuged for 5 min at 13,000× g at room
temperature. The supernatant was transferred into fresh PCR-grade 1.75 mL tubes. 30 µL of Proteinase
K was added to the supernatant, mixed and kept for 10 min at 70 ◦C. 30 µL of PowerMag Inhibitor
Removal Solution was then added to each sample and mixed well. The samples were incubated
at room temperature for 5 min and then were again centrifuged at 13,000× g and the supernatants
transferred to a fresh 2 mL Deep Well Plate, ensuring no transfer of any residual pellet. 5 µL of RNAse
was added to each well of this Deep Well Plate.
The extraction method was completed on the Eppendorf epMotion 5075TMX platform following
the manufactures instructions using the PowerMag Microbiome DNA Isolation kit. Reagents used
in this programme included Clear Mag Wash Solution, the Clear Mag Binding Solution and Clear
Mag Beads. Briefly, using the automated wash and elution protocol, beads and a binding solution
were added to each well and mixed together. In this process, the DNA would adhere to the beads
after which the plate was transported to a magnet and the waste removed. This process was repeated
3 times with the lysate and binding solution followed by an ethanol wash. Low heat was applied to
remove traces of ethanol and an elution buffer was added. This released the nucleic acids from the
beads and the elute was separated from the beads and stored at −80 ◦C.
Table A1. PCR primers and their amplification conditions.
Target Primers
Sequence
(5′–3′)
Conc (nM)
Annealing
References
Temp (◦C) Time (s)
Total Bacteria
UnivF TCCTACGGGAGGCAGCAGT
500 60 45 [35]UnivR GGACTACCAGGGTATCTATCCTGTT
Lactobacillus
Spp
Lacto-F AGCAGTAGGGAATCTTCCA
500 56 20 [36]Lacto-R CACCGCTACACATGGAG
Bifidobacterium
Spp
Bifi-F TCGCGTCCGGTGTGAAAG
500 56 20 [37]Bifi-R CCACATCCAGCGTCCAC
Appendix A.3. qPCR
All qPCR analysis was performed on the CFX 384TM real-time PCR detection system (Bio-Rad,
Hercules). Reactions were performed in triplicate, with a total reaction volume of 10 µL. Each reaction
consisted of 3 µL (2.8 ng/µL) of DNA template and 7 µL PCR mixture containing 5µL of SYBR
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mix, bovine serum albumin (0.2 µL), forward (0.1 µL) and reverse primers (0.1 µL) (2.5 ng/µL) and
PCR-grade water (1.6 µL). The qPCR cycling conditions had an initial hot start at 98 ◦C for 3 min,
followed by 35 cycles of two step qPCR with denaturing at 98 ◦C for 15 s using the annealing/elongation
temperatures as in Table 1. Fluorescence intensities were detected during the last step of each cycle.
qPCR melting curves were obtained after amplification by continuously collecting fluorescence intensity
measurements as the reactions were slowly heated from 55 to 95 ◦C in increments of 0.50 ◦C/s.
Appendix A.4. Next Generation Sequencing
The methods outlined in Illumina’s “16S Metagenomic Sequencing Library Preparation” protocol
were followed [38] with adjustments made to PCR thermal cycle conditions, as detailed below.
The hypervariable region V4 of the 16SrRNA gene was amplified from the extracted DNA using
modified primer pairs with Illumina adapter overhang sequences. The full-length primer sequences
using standard IUPAC nucleotide nomenclature were:
16S Amplicon PCR Forward Primer =
5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA-3′
Amplicon PCR Reverse Primer =
5′-TCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT-3′
A two-step PCR process was required. The PCR reaction contained 5 µL of forward primer (1 nM),
5 µL of reverse primer (1 nM) and 12.5 µL of 2 × KAPA H-iFi Hotstart ReadyMix (KAPA Biosystems,
Wilmington, MA, USA) in a total volume of 25 µL. The PCR reaction was performed on a Veriti Thermal
Cycler (Thermo Fisher Scientific, Waltham, MA, USA) using the following programme: 25 cycles of
95 ◦C for 30 s, 55 ◦C for 30 s, 72 ◦C for 30 s followed by holding at 72 ◦C for a further 5 min. Following
a clean-up of the PCR product, indexing PCR was performed. This step used the Nextera XT Index
Kit to attach the dual indices and the Illumina sequencing adapters. The manufacturer’s instructions
were followed as described in the Illumina library preparation protocol, as mentioned above. The final
library was pair-end sequenced using a MiSeq Reagent Kit v3 on the Illumina MiSeq platform. Library
preparation and sequencing was performed at Flinders University, South Australia. A standard t-test
was used to compare the relative abundances of control and test groups at the different taxonomic
levels (see Table A2).
Table A2. Percent abundance of the dominant major bacterial taxa at each taxonomic level.
Taxonomy
Preweaning (n = 15) Weaning (n = 14)
Control HAMS p Value Control HAMS p Value mHAMS p Value
Phylum
Actinobacteria 12.50 15.48 0.35 10.16 18.55 0.004 17.88 0.004
Bacteroidetes 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.03
Firmicutes 33.33 37.74 0.09 33.5 32.51 0.79 34.37 0.11
Proteobacteria 46.23 39.39 0.17 51.27 35.76 0.001 32.06 0.004
Class/subclass
Actinobacteria 12.51 15.48 0.35 10.17 18.56 0.004 17.88 0.004
Bacilli 13.46 18.74 0.02 14.48 16.83 0.32 19.04 0.08
Bacteroidia 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.001
Clostridia 17.71 16.28 0.58 16.25 12.31 0.26 10.79 0.07
Gammaproteobacteria 46.10 39.13 0.17 50.69 35.19 <0.001 31.56 <0.001
Order
Bacteroidales 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.001
Bifidobacteriales 11.64 14.73 0.32 9.12 16.83 0.01 16.33 0.01
Clostridiales 17.71 16.27 0.58 16.24 12.30 0.26 10.79 0.07
Enterobacteriales 45.98 39.04 0.17 50.61 35.16 <0.001 31.51 <0.001
Erysipelotrichales 1.77 1.73 0.93 0.25 0.54 0.07 0.77 0.09
Lactobacillales 12.81 17.67 0.03 14.44 16.58 0.36 19.03 0.08
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Table A2. Cont.
Taxonomy
Preweaning (n = 15) Weaning (n = 14)
Control HAMS p Value Control HAMS p Value mHAMS p Value
Family
Bifidobacteriaceae 11.67 14.82 0.32 9.31 17.54 0.007 16.86 0.004
Bacteroidaceae 7.49 7.06 0.89 4.60 12.91 <0.001 14.34 0.002
Enterococcaceae 12.42 17.04 0.03 12.79 13.96 0.61 16.32 0.16
Clostridiceae 14.58 13.44 0.67 7.71 5.22 0.27 4.98 0.13
Erysipelotrichaceae 1.77 1.73 0.94 0.26 0.55 0.07 0.78 0.08
Peptostreptococcaceae 1.99 1.57 0.45 3.14 0.94 0.04 0.54 0.02
Ruminococcaceae 0.42 0.34 0.34 1.59 1.46 0.62 2.02 0.28
Enterobacteriaceae 46.12 39.19 0.17 51.19 35.88 <0.001 32.20 <0.001
Genus
Bacteroides 7.48 7.02 0.89 4.54 12.56 0.009 13.92 0.002
Bifidobacterium 11.64 14.73 0.32 9.12 16.83 0.006 16.33 0.006
Clostridium 14.53 13.38 0.67 7.44 5.09 0.27 4.78 0.11
Enterobacter 30.31 24.89 0.21 32.32 18.21 <0.001 15.02 <0.001
Enterococcus 12.40 16.99 0.03 12.72 13.75 0.65 16.12 0.18
Escherichia/Shigella 15.05 13.67 0.73 16.39 15.88 0.73 15.59 0.67
Ruminococcus 0.22 0.17 0.43 0.50 0.56 0.58 1.35 0.01
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